Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

640

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

June 2, 2026

Study Completion Date

June 2, 2026

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Durvalumab

Durvalumab intravenous infusion

DRUG

Placebo

Durvalumab matching placebo for intravenous infusion

DRUG

cisplatin + fluorouracil

cisplatin + fluorouracil, as per Standard of Care

DRUG

cisplatin + capecitabine

cisplatin + capecitabine, as per Standard of Care

RADIATION

Radiation

50-64Gy in total

Trial Locations (133)

333

Research Site, Taoyuan District

407

Research Site, Taichung

710

Research Site, Tainan City

1090

Research Site, Brussels

4000

Research Site, Liège

5000

Research Site, Namur

6060

Research Site, Charleroi

8035

Research Site, Barcelona

10002

Research Site, Taipei

10210

Research Site, Bangkok

10300

Research Site, Bangkok

10330

Research Site, Bangkok

10400

Research Site, Bangkok

11217

Research Site, Taipei

14004

Research Site, Córdoba

16247

Research Site, Suwon

21280

Research Site, Diyarbakır

22000

Research Site, Chanthaburi

22031

Research Site, Fairfax

25030

Research Site, Besançon

25240

Research Site, Erzurum

26506

Research Site, Morgantown

28007

Research Site, Madrid

28034

Research Site, Madrid

28046

Research Site, Madrid

30308

Research Site, Atlanta

31008

Research Site, Pamplona

31210

Research Site, Chihuahua City

34070

Research Site, Montpellier

35575

Research Site, Izmir

39008

Research Site, Santander

40002

Research Site, Khon Kaen

40217

Research Site, Louisville

40443

Research Site, Taichung

41404

Research Site, Daegu

46000

Research Site, Changzhi

50006

Research Site, Changhua

50009

Research Site, Zaragoza

50200

Research Site, Chiang Mai

51100

Research Site, Reims

59000

Research Site, Lille

62290

Research Site, Cuernavaca

65080

Research Site, Van

66220

Research Site, Monterrey

67033

Research Site, Strasbourg

69008

Research Site, Lyon

75390

Research Site, Dallas

76031

Research Site, Rouen

80756

Research Site, Kaohsiung City

82445

Research Site, Kaohsiung City

83301

Research Site, Kaohsiung City

90110

Research Site, Hat Yai

91851

Research Site, Veracruz

94805

Research Site, Villejuif

97134

Research Site, Mérida

100000

Research Site, Hanoi

100021

Research Site, Beijing

100036

Research Site, Beijing

115478

Research Site, Moscow

197758

Research Site, Saint Petersburg

212002

Research Site, Zhenjiang

221000

Research Site, Xuzhou

222002

Research Site, Liangyugang

223300

Research Site, Huai'an

225001

Research Site, Yangzhou

226361

Research Site, Nantong

230031

Research Site, Hefei

233004

Research Site, Bengbu

249031

Research Site, Obninsk

250117

Research Site, Jinan

266042

Research Site, Qingdao

300060

Research Site, Tianjin

350001

Research Site, Fuzhou

350014

Research Site, Fuzhou

350040

Research Site, Krasnodar

362000

Research Site, Quanzhou

400030

Research Site, Chongqing

410013

Research Site, Changsha

450008

Research Site, Zhengzhou

450054

Research Site, Ufa

454087

Research Site, Chelyabinsk

455000

Research Site, Anyang

510000

Research Site, Guangzhou

510060

Research Site, Guangzhou

518116

Research Site, Shenzhen

522000

Research Site, Jieyang

610042

Research Site, Chengdu

620905

Research Site, Yekaterinburg

650118

Research Site, Kunming

700000

Research Site, Ho Chi Minh City

710061

Research Site, Xi'an

6250041

Research Site, Tyumen

14784-400

Research Site, Barretos

60430-230

Research Site, Fortaleza

90050-170

Research Site, Porto Alegre

91350-200

Research Site, Porto Alegre

20231-050

Research Site, Rio de Janeiro

15090-000

Research Site, São José do Rio Preto

29043-260

Research Site, Vitória

L4M 6M2

Research Site, Barrie

P3E 5J1

Research Site, Greater Sudbury

Unknown

Research Site, Hangzhou

Research Site, Goztepe Istanbul

Research Site, Ho Chi Minh City

113-8431

Research Site, Bunkyō City

104-0045

Research Site, Chūōku

350-1298

Research Site, Hidaka-shi

573-1191

Research Site, Hirakata-shi

730-8518

Research Site, Hiroshima

277-8577

Research Site, Kashiwa

362-0806

Research Site, Kitaadachi-gun

135-8550

Research Site, Kōtoku

860-8556

Research Site, Kumamoto

371-8511

Research Site, Maebashi

791-0280

Research Site, Matsuyama

951-8566

Research Site, Niigata

700-8558

Research Site, Okayama

541-8567

Research Site, Osaka

545-8586

Research Site, Osaka

373-8550

Research Site, Ota-shi

980-8574

Research Site, Sendai

142-8666

Research Site, Shinagawa-ku

232-0024

Research Site, Yokohama

241-8515

Research Site, Yokohama

40-074

Research Site, Katowice

31-115

Research Site, Krakow

90-513

Research Site, Lodz

08-110

Research Site, Siedlce

02-034

Research Site, Warsaw

06273

Research Site, Seoul

06351

Research Site, Seoul

138-736

Research Site, Seoul

06800

Research Site, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY